Sign in Register

Drug class

Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC

The phrase "Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC" represents a composite clinical and formulary categorization rather than a single pharmacologic drug class. Read more about Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC

34 drugs in this class 33 manufacturers

Advertisement

Related classes & indications

Proton Pump InhibitorsGastrointestinal · 219 prescription drugs Histamine-2 Receptor Antagonists (H2 Antagonists)Gastrointestinal · 78 prescription drugs Chronic Idiopathic ConstipationTop indication · 37 prescription drugs

Drugs in Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC

Showing 1–9 of 34 drugs

TRULANCE (plecanatide)

IRRITABLE BOWEL SYNDROME AGENTS · CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME ·+1
SALIX/BAUSCH HE

AMITIZA (lubiprostone)

IRRITABLE BOWEL SYNDROME AGENTS · CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME ·+2
Takeda Pharmaceuticals America

LINZESS (linaclotide)

IRRITABLE BOWEL SYNDROME AGENTS · CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME ·+2
Allergan

TRULANCE (plecanatide)

IRRITABLE BOWEL SYNDROME AGENTS · CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME ·+1
SALIX PHARMACEU

AMITIZA (lubiprostone)

IRRITABLE BOWEL SYNDROME AGENTS · CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME ·+2
SpecGx

LUBIPROSTONE

IRRITABLE BOWEL SYNDROME AGENTS · CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME ·+2
TEVA PHARM
Filter & compare in the drug finder → Opens the drug finder with Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC preselected. Add indication or manufacturer filters there.

About Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC.

The phrase "Agents to Treat Chronic Idiopathic Constipation/IBS-C/OIC" represents a composite clinical and formulary categorization rather than a single pharmacologic drug class.

It encompasses several distinct mechanistic classes—most notably intestinal secretagogues like guanylate cyclase-C agonists and chloride channel activators, 5-HT4 receptor agonists, and peripherally acting mu-opioid receptor antagonists.

Functioning to increase intestinal fluid secretion, accelerate gastrointestinal transit, or reverse opioid-induced bowel dysfunction, these medications provide targeted symptom management beyond conventional laxatives.

They are indicated for adults with chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and opioid-induced constipation (OIC).